LONDON, October 25, 2018 /PRNewswire/ --
Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others
The global respiratory inhalers market reached $33bn in 2017 and is estimated to reach $38bn by 2023. In 2017, the asthma segment held 58% of the global respiratory inhalers
(Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 165-page report you will receive 121 charts- all unavailable elsewhere.
The 165-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Global Respiratory Inhalers Market from 2018-2028
Forecast of the Global Respiratory Inhalers market by Type of Product: Metered Dose Inhalers (MDIs) Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers
Forecast of the Global Respiratory Inhalers market by Indication: Asthma COPD Other Respiratory Diseases
This report provides individual revenue forecasts to 2028 for these national markets: The US Germany France UK Italy Spain Japan China India Russia Brazil Mexico Canada
Our study discusses the selected leading companies that are the major players in the respiratory inhalers market: AstraZeneca Boehringer Ingelheim Chiesi Farmaceutici S.p.A. GlaxoSmithKline (GSK) Merck & Co. Novartis Teva
This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.
This report discusses the Porter's Five Forces Analysis of the respiratory inhalers market.
Visiongain's study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.
To request a report overview of this report please contact Sara Peerun at firstname.lastname@example.org or refer to our website: https://www.visiongain.com/report/the-global-respiratory-inhalers-market-2018-2028/
3M Drug Delivery Systems Actavis Adherium Limited Aerogen Agilent Technology Airssential Allied Healthcare Almirall Astrazeneca Boehringer Ingelheim Briggs Healthcare CareFusion Chiesi Circassia Pharmaceuticals plc Cipla Clement Clarke International Cohero Health DeVilbiss Healthcare Fexicare Gecko Health Innovations GF Health Products GlaxoSmithKline Heyer Medical Hikma IBM Watson Health Innovate Biomed Innoviva Inspiro Medical Mabis Healthcare Medline Surgical Merck MRK Healthcare Mylan Nexus 6 Nouvag AG Novartis Omron Healthcare Opko Health Orion Pharma PARI Medical Pfizer Philips Respironics Propeller Health Qualcomm Incorporated Roche Schering-Plough Sunovion Pharma Takeda Pharmaceutical Company Limited Teva Pharmaceuticals Theravance Vectura Viatris List of Organizations Mentioned in the Report British Lung Foundation Centers for Disease Control and Prevention Centre for Devices and Radiological Health European Databank on Medical Devices European Medicines Agency European Respiratory Society Food and Drug Administration German Ministry of Health Global Initiative for Asthma Global Initiative for Chronic Obstructive Lung Disease IBM Watson Health Kaohsiung Medical University Ministry of Health, Labour and Welfare Mount Sinai Hospital MRC Technology ServicioSanitarioNazionale UK NHS US National Heart, Lung, and Blood Institute US National Institutes of Health Weill Cornell Medicine World Health Organization (WHO)
To see a report overview please e-mail Sara Peerun on email@example.com
Subscribe to our Free Newsletters!